Cargando…
Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis
Bone is one of the preferred sites for the metastasis of malignant tumours, such as breast cancer, lung cancer and malignant melanoma. Tumour cells colonizing bone have the capacity to induce the expression of receptor activator of nuclear factor-κB ligand (RANKL), which promotes osteoclast differen...
Autores principales: | Nakai, Yuta, Okamoto, Kazuo, Terashima, Asuka, Ehata, Shogo, Nishida, Jun, Imamura, Takeshi, Ono, Takashi, Takayanagi, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315020/ https://www.ncbi.nlm.nih.gov/pubmed/30622830 http://dx.doi.org/10.1038/s41413-018-0036-5 |
Ejemplares similares
-
The crucial role of osteocyte-derived RANKL in bone homeostasis
por: Nakashima, Tomoki, et al.
Publicado: (2012) -
Identification of an intronic enhancer regulating RANKL expression in osteocytic cells
por: Yan, Minglu, et al.
Publicado: (2023) -
Simultaneous augmentation of muscle and bone by locomomimetism through calcium-PGC-1α signaling
por: Ono, Takehito, et al.
Publicado: (2022) -
Regulation of RANKL signaling in arthritic bone destruction
por: Takayanagi, H
Publicado: (2003) -
IL-17-producing γδ T cells enhance bone regeneration
por: Ono, Takehito, et al.
Publicado: (2016)